EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 29 / No 5 (Mai 2013) Med Sci (Paris), 29 5 (2013) 463-468 References
Free Access
Issue
Med Sci (Paris)
Volume 29, Number 5, Mai 2013
Page(s) 463 - 468
Section Nouvelles
DOI https://doi.org/10.1051/medsci/2013295007
Published online 28 May 2013
  1. Patti GJ, Yanes O, Siuzdak G. Innovation: metabolomics: the apogee of the omics trilogy. Nat Rev Mol Cell Biol 2012 ; 13 : 263–269. [CrossRef] [PubMed] [Google Scholar]
  2. Ricquier D. Maladies héréditaires du métabolisme et apports de la métabolomique. Med Sci (Paris) 2005 ; 21 : 512–516. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  3. Smolinska A, Blanchet L, Buydens LM, Wijmenga SS. NMR and pattern recognition methods in metabolomics: from data acquisition to biomarker discovery: a review. Anal Chim Acta 2012 ; 750 : 82–97. [CrossRef] [PubMed] [Google Scholar]
  4. Zhang A, Sun H, Wang P, et al. Recent and potential developments of biofluid analyses in metabolomics. J Proteomics 2012 ; 75 : 1079–1088. [CrossRef] [PubMed] [Google Scholar]
  5. Ganti S, Taylor SL, Abu Aboud O, et al. Kidney tumor biomarkers revealed by simultaneous multiple matrix metabolomics analysis. Cancer Res 2012 ; 72 : 3471–3479. [CrossRef] [PubMed] [Google Scholar]
  6. Weiss RH, Kim K. Metabolomics in the study of kidney diseases. Nat Rev Nephrol 2011 ; 8 : 22–33. [CrossRef] [PubMed] [Google Scholar]
  7. Ganti S, Weiss RH. Urine metabolomics for kidney cancer detection and biomarker discovery. Urol Oncol 2011 ; 29 : 551–557. [CrossRef] [PubMed] [Google Scholar]
  8. Mitrevski BS, Kouremenos KA, Marriott PJ. Accelerating analysis for metabolomics, drugs and their metabolites in biological samples using multidimensional gas chromatography. Bioanalysis 2009 ; 1 : 367–391. [CrossRef] [PubMed] [Google Scholar]
  9. Vuckovic D. Current trends and challenges in sample preparation for global metabolomics using liquid chromatography-mass spectrometry. Anal Bioanal Chem 2012 ; 403 : 1523–1548. [CrossRef] [PubMed] [Google Scholar]
  10. Lei Z, Huhman DV, Sumner LW. Mass spectrometry strategies in metabolomics. J Biol Chem 2011 ; 286 : 25435–25442. [CrossRef] [PubMed] [Google Scholar]
  11. Barding GA, Jr, Salditos R, Larive CK. Quantitative NMR for bioanalysis and metabolomics. Anal Bioanal Chem 2012 ; 404 : 1165–1179. [CrossRef] [PubMed] [Google Scholar]
  12. Casado-Vela J, Cebrian A, Gomez del Pulgar MT, Lacal JC. Approaches for the study of cancer: towards the integration of genomics, proteomics and metabolomics. Clin Transl Oncol 2011 ; 13 : 617–628. [CrossRef] [PubMed] [Google Scholar]
  13. D’Alessandro A, Zolla L. Metabolomics and cancer drug discovery: let the cells do the talking. Drug Discov Today 2011 ; 17 : 3–9. [CrossRef] [PubMed] [Google Scholar]
  14. Issaq HJ, Fox SD, Chan KC, Veenstra TD. Global proteomics and metabolomics in cancer biomarker discovery. J Sep Sci 2011 ; 34 : 3484–3492. [CrossRef] [PubMed] [Google Scholar]
  15. Metallo CM. Expanding the reach of cancer metabolomics. Cancer Prev Res (Phila) 2012 ; 5 : 1337–1340. [CrossRef] [PubMed] [Google Scholar]
  16. Claudino WM, Goncalves PH, di Leo A, et al. Metabolomics in cancer: a bench-to-bedside intersection. Crit Rev Oncol Hematol 2012 ; 84 : 1–7. [CrossRef] [PubMed] [Google Scholar]
  17. Ikeda A, Nishiumi S, Shinohara M, et al. Serum metabolomics as a novel diagnostic approach for gastrointestinal cancer. Biomed Chromatogr 2012 ; 26 : 548–558. [CrossRef] [PubMed] [Google Scholar]
  18. Nishiumi S, Kobayashi T, Ikeda A, et al. A novel serum metabolomics-based diagnostic approach for colorectal cancer. PLoS One 2012 ; 7 : e40459. [CrossRef] [PubMed] [Google Scholar]
  19. Bertini I, Cacciatore S, Jensen BV, et al. Metabolomic NMR fingerprinting to identify and predict survival of patients with metastatic colorectal cancer. Cancer Res 2012 ; 72 : 356–364. [CrossRef] [PubMed] [Google Scholar]
  20. Cao M, Zhao L, Chen H, et al. NMR-based metabolomic analysis of human bladder cancer. Anal Sci 2012 ; 28 : 451–456. [CrossRef] [PubMed] [Google Scholar]
  21. Wei S, Liu L, Zhang J, et al. Metabolomics approach for predicting response to neoadjuvant chemotherapy for breast cancer. Mol Oncol 2012 pii: S1574–7891(12)00101–9 [Google Scholar]
  22. Budczies J, Denkert C, Muller BM, et al. Remodeling of central metabolism in invasive breast cancer compared to normal breast tissue -a GC-TOFMS based metabolomics study. BMC Genomics 2012 ; 13 : 334. [CrossRef] [PubMed] [Google Scholar]
  23. Eckhart AD, Beebe K, Milburn M. Metabolomics as a key integrator for «omic» advancement of personalized medicine and future therapies. Clin Transl Sci 2012 ; 5 : 285–288. [CrossRef] [PubMed] [Google Scholar]
  24. Wishart DS, Jewison T, Guo AC, et al. HMDB 3.0-The human metabolome database in 2013. Nucleic Acids Res 2013 ; 41 : D801–D807. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.